Intravascular molecular-structural imaging with a miniaturized integrated near-infrared fluorescence and ultrasound

Stephan Kellnberger1, Georg Wissmeyer1, Mazen Albaghdadi1

  • 1Cardiovascular Research Center, Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts, USA.

Insights

A new hybrid catheter combines near-infrared fluorescence (NIRF) and intravascular ultrasound (IVUS) for simultaneous molecular-structural imaging of coronary arteries. This innovation promises improved assessment and treatment of coronary artery disease (CAD).

Area of Science:

  • Cardiovascular Imaging
  • Biomedical Engineering
  • Molecular Imaging

Background:

  • Coronary artery disease (CAD) is a major cause of death, necessitating advanced diagnostic tools.
  • Current imaging methods like intravascular ultrasound (IVUS) lack molecular information.
  • There is a need for integrated systems that provide both structural and molecular data for comprehensive CAD assessment.

Purpose of the Study:

  • To develop and evaluate a miniaturized, hybrid intravascular catheter system for simultaneous near-infrared fluorescence (NIRF) and IVUS imaging.
  • To assess the feasibility of this hybrid catheter for in vitro and in vivo imaging of coronary arteries.
  • To demonstrate the potential of combined molecular and structural imaging for characterizing CAD.

Main Methods:

  • Development of a 1.0 mm (3.0 French) hybrid catheter integrating NIRF and IVUS capabilities.
  • In vitro testing using coronary stents and NIR fluorophores to compare sensor designs.
  • In vivo intravascular imaging in pig coronary arteries to demonstrate simultaneous, co-registered molecular-structural imaging of inflammation.

Main Results:

  • The hybrid catheter achieved simultaneous NIRF-IVUS imaging in vitro and in vivo.
  • Demonstrated co-registered molecular-structural imaging of experimental CAD inflammation in pig coronary arteries.
  • Compared NIRF signal strengths for different sensor designs in various scattering media.

Conclusions:

  • The NIRF-IVUS catheter system offers a significant advancement over standalone IVUS.
  • This technology enables comprehensive phenotyping of vascular disease, including inflammation.
  • Potential to improve patient assessment and treatment strategies for coronary artery disease.

Related Concept Videos